Effects of Educational Training on Children With Developmental Delay

July 31, 2021 updated by: Taipei Medical University

Therapeutic Effects of Individualized Educational Training on Preschool Children With Global Developmental Delay

Using a single-blind, randomized controlled design to investigate the additional therapeutic effects of individualized educational training on traditional rehabilitation programs for preschool children with developmental delays.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

A total of 20 preschool children with developmental delay who are receiving traditional rehabilitation programs will be enrolled.

The participants will be randomized into two groups, including the intervention group (traditional rehabilitation program with individualized educational training: one time per week, 50 min per session, with a total of 4 sessions in one month) and the control group (traditional rehabilitation program without individualized educational training).

Therapeutic effects, including pediatric daily activity, attention, cognitive function, functional performance, quality of life, and physical functional performance at baseline, after one month of treatment, and 3 months after the treatment, will be evaluated.

The evaluators will be blinded to the group's allocation during the whole course of the intervention.

Study Type

Interventional

Enrollment (Anticipated)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Taipei, Taiwan, 111-01
        • Shin Kong Wu Ho-Su Memorial Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

3 years to 6 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • preschool children with a diagnosis of developmental delay, under regular traditional rehabilitation programs, intelligence quotient 70 or greater

Exclusion Criteria:

  • age less than 3 or greater than 6 of children diagnosed with developmental delay, under regular traditional rehabilitation programs, intelligence quotient 70 or greater

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Intervention group
traditional rehabilitation programs with additional individualized educational training
50 min per session, one session per week, 4 sessions per month, of individualized educational training to preschool children with developmental delays under traditional rehabilitation programs
No Intervention: Control group
traditional rehabilitation programs without additional individualized educational training

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
changes of daily activity
Time Frame: score change from baseline to 1 month of treatment, and 3 months after treatment, lower scores mean a worse outcome
score assessed by Pediatric Daily Occupation Scale
score change from baseline to 1 month of treatment, and 3 months after treatment, lower scores mean a worse outcome
changes of attention
Time Frame: score change from baseline to 1 month of treatment, and 3 months after treatment, lower scores mean a worse outcome
score assessed by Conners Kiddie Continous Performance Test, 2nd edition
score change from baseline to 1 month of treatment, and 3 months after treatment, lower scores mean a worse outcome

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change of visual motor integration
Time Frame: score change from baseline to 1 month of treatment, and 3 months after treatment, lower scores mean a worse outcome
score assessed by Beery-Buktenica Visual Motor Integration
score change from baseline to 1 month of treatment, and 3 months after treatment, lower scores mean a worse outcome
change of intelligence
Time Frame: score change from baseline to 1 month of treatment, and 3 months after treatment, lower scores mean a worse outcome
score assessed by Wechsler Intelligence Scale of children
score change from baseline to 1 month of treatment, and 3 months after treatment, lower scores mean a worse outcome
Changes of functional performance
Time Frame: score change from baseline to 1 month of treatment, and 3 months after treatment, lower scores mean a worse outcome
score assessed by Pediatric Outcome Data Collection Instrument
score change from baseline to 1 month of treatment, and 3 months after treatment, lower scores mean a worse outcome
changes of quality of life
Time Frame: score change from baseline to 1 month of treatment, and 3 months after treatment, lower scores mean a worse outcome
score assessed by Pediatric Quality of Life Inventory
score change from baseline to 1 month of treatment, and 3 months after treatment, lower scores mean a worse outcome
changes of family impact
Time Frame: score change from baseline to 1 month of treatment, and 3 months after treatment, lower scores mean a worse outcome
score assessed by Child Health Questionnaire, parent form 28
score change from baseline to 1 month of treatment, and 3 months after treatment, lower scores mean a worse outcome
changes of walking speed
Time Frame: score change from baseline to 1 month of treatment, and 3 months after treatment, lower scores mean a worse outcome
walking speed
score change from baseline to 1 month of treatment, and 3 months after treatment, lower scores mean a worse outcome
changes of chair climbing speed
Time Frame: score change from baseline to 1 month of treatment, and 3 months after treatment, lower scores mean a worse outcome
stairs climbing speed
score change from baseline to 1 month of treatment, and 3 months after treatment, lower scores mean a worse outcome
changes of balance
Time Frame: score change from baseline to 1 month of treatment, and 3 months after treatment, lower scores mean a worse outcome
one leg standing time
score change from baseline to 1 month of treatment, and 3 months after treatment, lower scores mean a worse outcome
changes of balance and coordination
Time Frame: score change from baseline to 1 month of treatment, and 3 months after treatment, lower scores mean a worse outcome
timed up and go test
score change from baseline to 1 month of treatment, and 3 months after treatment, lower scores mean a worse outcome
changes of physical function
Time Frame: score change from baseline to 1 month of treatment, and 3 months after treatment, lower scores mean a worse outcome
5 times sit to stand test
score change from baseline to 1 month of treatment, and 3 months after treatment, lower scores mean a worse outcome

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

August 1, 2021

Primary Completion (Anticipated)

December 31, 2021

Study Completion (Anticipated)

December 31, 2021

Study Registration Dates

First Submitted

July 31, 2021

First Submitted That Met QC Criteria

July 31, 2021

First Posted (Actual)

August 3, 2021

Study Record Updates

Last Update Posted (Actual)

August 3, 2021

Last Update Submitted That Met QC Criteria

July 31, 2021

Last Verified

July 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 2021SKHADR032

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe